PAID for Participation - COPD/ Chronic Obstructive Pulmonary Disease

PAID for Participation - COPD/ Chronic Obstructive Pulmonary Disease

18 Oct 2024
Texas, Houston, 77001 Houston USA

PAID for Participation - COPD/ Chronic Obstructive Pulmonary Disease

Breathe Easier: Join Our COPD Clinical Trials!

Are you or someone you care about dealing with COPD? Take a step toward improved breathing by participating in our clinical trials aimed at discovering new treatments and enhancing COPD care. We are seeking patient volunteers to help us evaluate the effectiveness of a new medication for COPD. There’s no cost for the medication, and you’ll be compensated for your time and travel related to the study. Plus, if you refer a qualifying friend, you can earn a $100 bonus!

Call 281-540-2940 Now! Or Apply Here

Why Participate?

Compensation: Get compensated up to $800 with no cost to you or your insurance!

Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.

Free study medications: Study medication for COPD are given at no cost.

To qualify:

Must be male or female between 40-70 years of age

Have a documented diagnosis of COPD of at least 12 months prior to screening

Have a body Mass index (BMI) between 18.5 and 35 kg/m2

Be a current smoker or former smoker

Participants must be on 2 or more inhaled maintenance medications for management of their COPD for at least 3 months: Inhaled Corticosteroid + Long-Beta Agonist OR Inhaled Corticosteroid + Long-Beta Agonist + Long-Acting Muscarinic Antagonist

Check out our other studies!

Asthma Study

Cardiac Imaging Study

Future Studies

AND MANY MORE!

Gulf Coast Clinical Research

Get Involved Today! Your participation can help advance Asthma research and improve lives. If you're ready to take action, contact us at [281-540-2940] or visit gulfcoasttrials.com for more information.

Related jobs

Job Details

Jocancy Online Job Portal by jobSearchi.